AAIC 2022 and Biomarkers View overview page

Plasma versus neuroimaging biomarkers for Alzheimer’s disease clinical trials

Biomarkers of delirium incidence and severity

Developing novel digital biomarkers

Targeting neuroinflammation: identifying new targets using transcriptomics

Biomarkers for risk assessment and early diagnosis of AD

State of microglial and inflammatory markers in the AD field

Successful Aging after Elective Surgery: goals of the SAGES II study

Next steps in dementia biomarkers

Neuropsychiatric and behavioral markers of dementia risk

Directions for blood biomarker research for early AD diagnosis

Progress in the Davos Alzheimer’s Collaborative’s Global Cohort Development program

The Davos Alzheimer’s Collaborative

Using digital technology to build a truly global cohort in Alzheimer’s disease

The promise of reactive astrocytes as biomarkers

Prognostic blood biomarkers in the pre-clinical stages of Alzheimer’s disease

Research priorities to achieve widespread use of blood-based biomarkers in Alzheimer’s disease